US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist
  • 3.662
  • +0.032+0.88%
Trading Jul 29 10:01 ET
352.38MMarket Cap-1322P/E (TTM)

ADC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADC Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 6, 2024

Revenue(YoY)

18.05M

-4.94%
EPS(YoY)

-0.56

+23.29%
Analyst Rating

Strong Buy

Jun 30, 2024

ADC Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 19.886M--
--2024/Q2-- / 18.798M--
May 6, 20242024/Q118.053M / 18.102M--
Mar 13, 20242023/Q416.790M / 15.260M--
Nov 7, 20232023/Q314.493M / 15.158M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 19.886M--
--2024/Q2-- / 18.798M--
May 6, 20242024/Q118.053M / 18.102M--
Mar 13, 20242023/Q416.790M / 15.260M--
Nov 7, 20232023/Q314.493M / 15.158M--

Unlock Free Earnings Estimates

ADC Therapeutics Earnings Reports

  • ADC Therapeutics | 10-Q: Quarterly report

    May 6 06:43 ET

  • ADC Therapeutics | 10-K: Annual report

    Mar 13 12:28 ET

  • ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 7, 2023 07:13 ET

  • ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 8, 2023 07:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg